Browse by Journal Title

Article

Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella, G.G. and Sannino, A. and Esposito, G. and Perrino, C.
Trends in Cardiovascular Medicine 29 (3): 141-147. April 2019

The plakoglobin knock-out mouse: A paradigm for the molecular analysis of cardiac cell junction formation.
Ruiz, P. and Birchmeier, W.
Trends in Cardiovascular Medicine 8 (3): 97-101. April 1998

Transgenic animal models for hypertension research.
Paul, M. and Franz, W.M.
Trends in Cardiovascular Medicine 5 (3): 108-114. 1 January 1995

The tissue renin-angiotensin systems in cardiovascular disease.
Paul, M. and Bachmann, J. and Ganten, D.
Trends in Cardiovascular Medicine 2 : 94-99. 1 January 1992

Review

Aptamer binding and neutralization of beta(1)-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.
Haberland, A. and Wallukat, G. and Schimke, I.
Trends in Cardiovascular Medicine 21 (6): 177-182. August 2011

Role of the immune system in hypertensive target organ damage.
Kvakan, H. and Luft, F.C. and Mueller, D.N.
Trends in Cardiovascular Medicine 19 (7): 242-246. October 2009

LRP and PDGF signaling: a pathway to atherosclerosis.
Boucher, P. and Gotthardt, M.
Trends in Cardiovascular Medicine 14 (2): 55-60. February 2004

ErbB2 pathways in heart and neural diseases.
Garratt, A.N. and Ozcelik, C. and Birchmeier, C.
Trends in Cardiovascular Medicine 13 (2): 80-86. February 2003

Editorial

Pushing preeclampsia back to pre-preeclampsia.
Luft, F.C. and Dechend, R.
Trends in Cardiovascular Medicine 28 (8): 514-515. November 2018

Chronic thromboembolic pulmonary hypertension evolves diagnostically and therapeutically.
Luft, F.C.
Trends in Cardiovascular Medicine 27 (1): 38-40. January 2017

Approaching the Hayflick limit.
Luft, F.C.
Trends in Cardiovascular Medicine 25 (3): 240-242. April 2015